WALTER E. STAMM, M.D.; MARY McKEVITT, R.N.; GEORGE W. COUNTS, M.D.; KENNETH F. WAGNER, D.O.; MARVIN TURCK, M.D.; KING K. HOLMES, M.D., Ph.D.
Antimicrobial prophylaxis prevents recurrent urinary tract infections in susceptible women, but its cost effectiveness has not been studied. In a recent placebo-controlled trial of urinary prophylaxis; we also assessed cost effectiveness using a decision analysis model. In our hospital the direct cost of 1 patient year of urinary prophylaxis approximates the cost of treating one episode of cystitis. In women with a baseline infection rate of three per patient year, the annual cost of prophylaxis ($85.82) was less than treatment of acute episodes of infection ($392.30). Sensitivity analyses showed that in women with three infections per year, prophylaxis became cost effective when charges per episode exceeded $42.00. In women with frequent episodes of cystitis, prophylaxis will be cost effective in most practice settings.
STAMM WE, McKEVITT M, COUNTS GW, WAGNER KF, TURCK M, HOLMES KK. Is Antimicrobial Prophylaxis of Urinary Tract Infections Cost Effective?. Ann Intern Med. ;94:251–255. doi: 10.7326/0003-4819-94-2-251
Download citation file:
Published: Ann Intern Med. 1981;94(2):251-255.
Healthcare Delivery and Policy, Infectious Disease, Nephrology, Urinary Tract Infection, Urological Disorders.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use